Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

49
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
49
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

57
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
57
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

70
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
70
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

6.3K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The associations between maternal disability and perinatal outcomes among Black and/or Hispanic women in PRAMS.

BMC pregnancy and childbirth·2026
Same author

"It is important to me to know where the information is going": Views of adults with intellectual disability on data sharing in precision medicine research.

Genetics in medicine open·2026
Same author

Navigating data sharing in research.

American journal of human genetics·2026
Same author

Adults with Intellectual Disability and Consent to Precision Medicine Research: Using Supported Decision-Making to Facilitate First-Person Consent.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2026
Same author

Return of genome-informed risk-assessment results for common conditions to 23,840 adults and children: An eMERGE network study.

American journal of human genetics·2026
Same author

The Electronic Medical Records and Genomics study: Design and analytic framework for assessing the impact of genome-informed risk assessments.

American journal of human genetics·2026
Same journal

Harm Reduction as an Alternative to Mandated Drug Treatment.

The Hastings Center report·2026
Same journal

Rethinking Mandated Drug Treatment: Why Expanding Freedom Requires Structural Drug Policy Reform.

The Hastings Center report·2026
Same journal

Banning Gender-Affirming Treatment for Minors: The Supreme Court Speaks.

The Hastings Center report·2026
Same journal

Making the Move to a Learning System of Research Ethics.

The Hastings Center report·2026
Same journal

Musical Performance and Biomedical Human Enhancement: Ethnographic Perspectives on Bioethical Questions.

The Hastings Center report·2026
Same journal

Transformed but Not Cured: The Ethics of Describing Gene-Editing Therapy for Sickle Cell Disease.

The Hastings Center report·2026
See all related articles

Related Experiment Video

Updated: Feb 25, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.4K

The Precision Medicine Nation.

Maya Sabatello, Paul S Appelbaum

    The Hastings Center Report
    |July 28, 2017
    PubMed
    Summary
    This summary is machine-generated.

    The Precision Medicine Initiative (PMI) advances personalized healthcare by tailoring treatments to individual genetic and lifestyle factors. This analysis explores its ethical implications and the concept of "genomic citizenship" for equitable outcomes.

    More Related Videos

    Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
    13:24

    Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

    Published on: April 11, 2016

    12.3K
    Automating Tumor Implantation in Zebrafish Larvae for Cancer Research and Medicine
    06:14

    Automating Tumor Implantation in Zebrafish Larvae for Cancer Research and Medicine

    Published on: September 19, 2025

    1.1K

    Related Experiment Videos

    Last Updated: Feb 25, 2026

    Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
    10:28

    Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

    Published on: July 24, 2019

    16.4K
    Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
    13:24

    Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

    Published on: April 11, 2016

    12.3K
    Automating Tumor Implantation in Zebrafish Larvae for Cancer Research and Medicine
    06:14

    Automating Tumor Implantation in Zebrafish Larvae for Cancer Research and Medicine

    Published on: September 19, 2025

    1.1K

    Area of Science:

    • Genomics and Personalized Medicine
    • Bioethics and Sociopolitical Science

    Background:

    • The United States' Precision Medicine Initiative (PMI) aims to revolutionize healthcare through personalized approaches.
    • Precision medicine tailors disease diagnosis, treatment, and prevention to individual variability in genes, environment, and lifestyle.
    • Key PMI strategies include building a research cohort, fostering innovation, and empowering patients.

    Purpose of the Study:

    • To critically examine the ethical and sociopolitical dimensions of the Precision Medicine Initiative.
    • To analyze the concept of "genomic citizenship" and its associated normative obligations.
    • To identify and discuss the ethical, legal, and social challenges arising from the PMI.

    Main Methods:

    • Analysis draws on scholarship from nationalism and democracy studies.
    • Examines the construction of "genomic citizenship" within the PMI framework.
    • Considers potential ethical, legal, and social challenges and their implications.

    Main Results:

    • The PMI's implementation necessitates careful consideration of its ethical and sociopolitical impacts.
    • The concept of "genomic citizenship" raises specific normative obligations and potential challenges.
    • Proactive discussion of emerging issues can guide policy development for equitable and socially sensitive outcomes.

    Conclusions:

    • Addressing the ethical, legal, and social dimensions of the PMI is crucial for its success.
    • The analysis provides a framework for maximizing the initiative's potential for equitable outcomes.
    • Findings are applicable to other population-based precision medicine research programs.